Portfolio company
PhosPrint
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops laser bioprinting systems for tissue regeneration, enabling clinicians to print living cells onto biological surfaces during surgery.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Brinter
This company develops 3D-bioprinted regenerative medical implants for healthcare providers to treat patients requiring breast reconstruction and orthopedic repairs.
PLCOSKIN
This company manufactures 3D-printed biodegradable hybrid mesh scaffolds for reconstructive surgeons and hospitals to support natural soft tissue regeneration and healing.
Photosynthetic
The company produces high-speed volumetric 3D printers for manufacturing complex microstructures used by researchers in life sciences, optics, and medical device development.
PRINTYMED
This company produces biomimetic spider silk materials for medical researchers, healthcare providers, and cosmetic manufacturers to enable regenerative treatments and sustainable product formulations.
PolTiss
The company develops programmable biopolymers that form customised, biodegradable implants under UV radiation for surgeons and medical device manufacturers.
Klona Biotech
The company develops 3D-bioprinted structural human tissue implants, such as ligaments and tendons, for healthcare providers and patients requiring reconstructive surgery.
Refined Diagnostics
This company develops AI-powered laser imaging systems for real-time, stain-free tissue analysis and cancer diagnostics for surgeons, pathologists, and hospitals.
Cellbricks
Cellbricks develops 3D-bioprinted human tissue implants and vascularised therapeutics for patients with complex wounds, soft tissue defects and organ damage.
